Aurora Cannabis Inc. (NASDAQ:ACB) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Aurora Cannabis Inc. (NASDAQ:ACB) have earned a consensus recommendation of “Moderate Buy” from the five brokerages that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating, one has given a buy rating and two have issued a strong buy rating on the company.

A number of research firms recently commented on ACB. Wall Street Zen lowered shares of Aurora Cannabis from a “hold” rating to a “sell” rating in a research note on Friday, July 18th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aurora Cannabis in a research note on Wednesday, October 8th. Finally, Zacks Research upgraded Aurora Cannabis from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th.

Aurora Cannabis Stock Performance

ACB stock opened at $4.81 on Tuesday. The company has a 50-day simple moving average of $5.27 and a 200 day simple moving average of $4.99. The company has a quick ratio of 1.51, a current ratio of 2.97 and a debt-to-equity ratio of 0.06. Aurora Cannabis has a fifty-two week low of $3.42 and a fifty-two week high of $6.91.

Aurora Cannabis (NASDAQ:ACB) last released its earnings results on Wednesday, August 6th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of $0.18 by ($0.37). The company had revenue of $71.98 million for the quarter, compared to analyst estimates of $96.83 million. Aurora Cannabis had a negative net margin of 5.66% and a negative return on equity of 1.49%. As a group, research analysts predict that Aurora Cannabis will post 0.46 earnings per share for the current year.

Institutional Investors Weigh In On Aurora Cannabis

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Cubist Systematic Strategies LLC boosted its position in shares of Aurora Cannabis by 358.6% during the 1st quarter. Cubist Systematic Strategies LLC now owns 238,460 shares of the company’s stock valued at $1,047,000 after purchasing an additional 186,462 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in Aurora Cannabis by 4.1% during the first quarter. Goldman Sachs Group Inc. now owns 743,903 shares of the company’s stock valued at $3,266,000 after purchasing an additional 29,099 shares during the last quarter. TD Asset Management Inc boosted its holdings in Aurora Cannabis by 4.0% during the first quarter. TD Asset Management Inc now owns 60,949 shares of the company’s stock worth $267,000 after buying an additional 2,321 shares in the last quarter. Mackenzie Financial Corp boosted its holdings in Aurora Cannabis by 8.9% during the first quarter. Mackenzie Financial Corp now owns 27,783 shares of the company’s stock worth $122,000 after buying an additional 2,280 shares in the last quarter. Finally, Northwest & Ethical Investments L.P. acquired a new position in Aurora Cannabis in the first quarter worth approximately $452,000. 47.63% of the stock is currently owned by institutional investors.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.